Skip to content
Independent analysis of NHS open data
PharmaInsight

Teriflunomide

Malignant Disease and Immunosuppression Drugs affecting the immune response BNF 0802040AL
Data updated December 2025 Download CSV

Teriflunomide was dispensed in England in December 2025, with 1 items, down 50.0% on a year earlier.

1items -50%

Dispensed in December 2025

1items

Rolling 12 months

£519

Net ingredient cost · December 2025

Figure 1. Teriflunomide: national items dispensed by month

0 1 2 Oct 2021 Jul 2024 Oct 2024 Dec 2025 1 Oct 2021: 2 Aug 2022: 1 Jul 2024: 2 Sep 2024: 2 Oct 2024: 2 Dec 2024: 2 Feb 2025: 2 Dec 2025: 1

Source: NHSBSA Prescription Cost Analysis, to December 2025

Download CSV
Embed this chart

At a glance

  • Therapeutic class Drugs affecting the immune response
  • Presentations 1 shown
  • Average cost / item £518.92
  • Year on year Down 50.0% on a year earlier
What this is
Net ingredient cost is the list price before discounts and dispensing fees, not what the NHS finally pays.

Top presentations, December 2025

The individual products dispensed under Teriflunomide this month.

Presentations of Teriflunomide, December 2025
Presentation BNF code Items Net ingredient cost
Teriflunomide 14mg tablets 0802040ALAAAAAA 1 £519

Source: NHSBSA Prescription Cost Analysis · to December 2025 OGL v3.0

Where Teriflunomide is dispensed

The regions and dispensing practices with the highest Teriflunomide volumes.

Regional volumes from NHSBSA Prescription Cost Analysis; practice volumes from NHS dispensing data.

In NHS hospitals

Teriflunomide is also used in NHS secondary care. See the indicative hospital cost, monthly trend and the trusts using it most on the hospital medicines page.

Compare Teriflunomide with

Other medicines in the same BNF section, by prescribing volume.